Oxford Immunotec Global Plc (OXFD) Inventory Turnover Ratio, from third quarter 2020 to third quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Oxford Immunotec Global Plc  (NASDAQ: OXFD)
 

Oxford Immunotec Global Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2020, Oxford Immunotec Global Plc's inventory turnover ratio sequentially decreased to 1.19 in the third quarter 2020, unsurprisingly, as the Oxford Immunotec Global Plc markets continue to deteriorate, and OXFD's faces growing challenges to bring down its inventories. Oxford Immunotec Global Plc's average inventory processing period in the Sep 30 2020 quarter, has increased to 307 days, from 263 days, in the Jun 30 2020 quarter.

Within Healthcare sector 319 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1788 in the second quarter 2020, to 1830.

OXFD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Oxford Immunotec Global Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OXFD Inventory Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Inventory Growth 33.66 % 28.79 % 9.15 % 42.86 % 60.29 %
Y / Y Cost of Sales Growth -20.12 % -59.81 % -14.76 % -0.68 % 25.32 %
Inventory Turnover Ratio (TTM) 1.19 1.39 1.79 1.89 2.06
OXFD's Total Ranking # 1830 # 1788 # 1827 # 1836 # 1505
Average inventory processing period 306 264 204 193 177
Seq. Inventory Growth 2.14 % 18.15 % -2.18 % 13.22 % -1.58 %
Seq. Cost of Sales Growth 110.97 % -39.79 % -8.27 % -31.44 % 6.13 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 10
Healthcare Sector # 320
Overall Market # 1830

Inventory Turnover Ratio Statistics
High Average Low
5.62 3.93 1.19
(Jun 30 2017)   (Sep 30 2020)



OXFD Company Profile >> Back to OXFD Efficiency Comparisons >> Compare OXFD Inventory Turnover Ratio to its Competitors

Financial Statements
Oxford Immunotec Global Plc's Inventories $ 13 Millions Visit OXFD's Balance sheet
Oxford Immunotec Global Plc's Cost of Revenues TTM $ 14 Millions Visit OXFD's Income Statement
What are OXFD's Sales? Visit OXFD's Sales by Segment

Other Inventory Turnover Ratios
Oxford Immunotec Global Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OXFD's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OXFD's Competitors
Inventory Turnover Ratio for OXFD's Suppliers
Inventory Turnover Ratio for OXFD's Customers

You may also want to know
OXFD's Sales Growth Rates OXFD's Pe Price to earnings ratio OXFD's Receivables Turnover Ratio OXFD's Stock Quote
OXFD's Net Income Growth Rates OXFD's Ps Price to Sales ratio OXFD's Sales per Employee OXFD's Asset Turnover Ratio
OXFD's Net Margin OXFD's Pb Price to Book ratio OXFD's Financial Strength Ratios OXFD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2020 Inventories at quarter ending Sep 30 2020
Htg Molecular Diagnostics Inc  2.98 $ 4.349  Millions$ 1  Millions
Edap Tms Sa  2.98 $ 26.778  Millions$ 9  Millions
Revvity Inc  2.96 $ 1,269.232  Millions$ 429  Millions
Quanterix Corporation  2.96 $ 36.166  Millions$ 12  Millions
Waters Corporation  2.95 $ 985.188  Millions$ 334  Millions
Insulet Corporation  2.94 $ 312.388  Millions$ 106  Millions
Pacific Biosciences Of California Inc   2.93 $ 45.590  Millions$ 16  Millions
Conformis inc   2.91 $ 36.381  Millions$ 13  Millions
Abbott Laboratories  2.90 $ 13,944.000  Millions$ 4,810  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,259.962  Millions$ 435  Millions
Elite Pharmaceuticals Inc   2.89 $ 12.990  Millions$ 4  Millions
Athenex Inc   2.87 $ 92.792  Millions$ 32  Millions
Plus Therapeutics Inc   2.86 $ 0.306  Millions$ 0  Millions
Strata Skin Sciences Inc  2.84 $ 9.552  Millions$ 3  Millions
Heska Corporation  2.83 $ 96.222  Millions$ 34  Millions
Enovis Corp  2.83 $ 1,574.633  Millions$ 556  Millions
Phibro Animal Health Corporation  2.79 $ 542.490  Millions$ 195  Millions
Icad Inc  2.75 $ 7.958  Millions$ 3  Millions
Surmodics Inc   2.72 $ 15.317  Millions$ 6  Millions
Pro dex Inc   2.71 $ 22.347  Millions$ 8  Millions
Standard Biotools Inc   2.71 $ 46.448  Millions$ 17  Millions
10x Genomics Inc   2.70 $ 55.051  Millions$ 20  Millions
Iridex Corp  2.69 $ 20.979  Millions$ 8  Millions
Lifevantage Corp  2.67 $ 38.172  Millions$ 14  Millions
Adaptive Biotechnologies Corporation  2.67 $ 27.247  Millions$ 10  Millions
Zeo Scientifix Inc   2.65 $ 0.399  Millions$ 0  Millions
Livanova Plc  2.65 $ 457.476  Millions$ 172  Millions
Koru Medical Systems Inc   2.64 $ 9.755  Millions$ 4  Millions
Boston Scientific Corporation  2.61 $ 4,047.000  Millions$ 1,549  Millions
Akebia Therapeutics Inc   2.57 $ 270.821  Millions$ 105  Millions

Date modified: 2026-06-22T16:30:25+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.